An Evaluation of Pharmacists‘ Expectations Towards Pharmacogenomics

Denus, Simon de; Letarte, Nathalie; Hurlimann, Thierry; Lambert, Jean‐Philippe; Lavoie, Annie; Robb, Laura; Sheehan, Nancy L.; Turgeon, Jacques; Vadnais, Barbara

doi:10.2217/pgs.12.197

Cited by 73 publications

(97 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…25 Three surveys were qualitative, that used one or combination of semi structure questionnaire, one-day meeting and case scenarios, 9,22,26 and with regard to design, four research were cohort study, 19,21,24,26 while the rest nine were Crosssectional studies, 9,12,15,16,18,[22][23][24][25] Pharmacogenetics or PG or pharmacogenetic testing and pharmacists or pharmacy students were discussed in all the articles. Table 1 presented the summary of included researches in this systematic review.…”

Section: Resultsmentioning

confidence: 99%

“…Seven studies have had a response rate of less than 60% for pharmacists, 12,15,16,18,19,23 while the remaining six have response rate more than 60%, 9,17,21,22,25 Only three researches used statistical analysis in questionnaire validation; 12,18,21 two studies used pilot study to validate the questionnaire in the studies; 17,19 majority of studies used experts reviews or kept silence on validity of questionnaire. 9,15,16,[22][23][24][25][26] In total 4,624 pharmacists participated in the reviewed articles.…”

Section: Resultsmentioning

confidence: 99%

“…19 This finding is in similar to research conducted in Australia, Malaysia and Nigeria respectively. 12,22,24 The remaining articles did not discuss ethical or legal concerns issues. …”

Section: Attitude-ethicalmentioning

confidence: 99%

See 2 more Smart Citations

Knowledge, Attitude and Practice Concerning Pharmacogenomics among Pharmacists: A Systematic Review

Yau¹,

Aziz²,

Haque³

2015

JYP

View full text Add to dashboard Cite

Background: Pharmacists are furnished with expert drug knowledge and have been considered as valuable resource of drug information, therefore, are well positioned to play a leading role in the application of pharmacogenomics (PG) in to clinical practice. This might prevent Chemotherapy related adverse events and improve patient outcomes, despite the ethical, privacy concerns and potential implications of lifelong genetic-data. Methods: This review is to evaluate and digest the various studies on Knowledge, Attitudes and Practice concerning pharmacogenomics among pharmacists and to suggest future research areas. 13 English published studies from 2004 to 2014 were selected. Studies involving Pharmacists of different area of practice and covering research from different continents were selected. Only studies on attitudes, knowledge and practice concerning pharmacogenetics among pharmacists from 2004 to 2014, and research articles published in English were selected. Non-research articles, studies done on general public; studies conducted among other healthcare professionals; studies on genetics of diseases or toxicogenetics were excluded. Results: Knowledge and practice regarding pharmacogenetics among pharmacists were poor despite good attitudes. There was knowledge advancement from 38% in 2005 to more than 50% 2013 in some countries. Some barriers to adoption of pharmacogenomics into patient care and interventional recommendations were highlighted. Conclusion: there is an urgent call for additional training of Pharmacogenomics among pharmacists and to incorporate pharmacogenomics into curriculum of pharmacy schools. Pharmacists and future pharmacists should be trained on how to critically evaluate the use, efficacy, and safety of available pharmacogenetic testing.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Knowledge, Attitude and Practice Concerning Pharmacogenomics among Pharmacists: A Systematic Review

Yau¹,

Aziz²,

Haque³

2015

JYP

View full text Add to dashboard Cite

show abstract

“…40 Additional studies with medical students in the US and in the UK indicate that they also share the same concerns. 41 Students who participated in this study reported an increased level of confidence with respect to their knowledge base.…”

Section: (89) 7 (11)mentioning

confidence: 99%

“…41 Students who participated in this study reported an increased level of confidence with respect to their knowledge base. As mentioned in the introduction, previous studies have shown that pharmacists were not aware of the pharmacogenomics information in FDA labeling, 40 which was one of the reasons for incorporating a team activity involving FDA and CPIC recommendations 42 as part of the course design.…”

Section: (89) 7 (11)mentioning

confidence: 99%

An Effective Approach to Teaching Pharmacogenomics in the First Year of Pharmacy Curriculum

Gálvez-Peralta

Szklarz

Geldenhuys

et al. 2018

American Journal of Pharmaceutical Education

View full text Add to dashboard Cite

Objective. To develop an effective method in teaching pharmacogenomics as a part of a new course, Biopharmaceutics and Pharmacogenomics. Methods. Teaching effectiveness was measured by quizzes, retrospective pre-and post-surveys, team activities, and journal reflections. Four team activities were included in the course: genomic disease, patient case, genetic counselor and a debate about personalized medicine. Outcomes and course impact were evaluated at the end of the course. The evaluation methods included the assessment of knowledge, students' perceptions regarding the utility of team activities, the impact of the course on students' confidence to discuss pharmacogenomics with health care providers or patients, and long-term knowledge retention, measured in the following P2 semester. Results. Seventy-six students were enrolled in the course. Multiple assessments during the course demonstrated that students' knowledge of pharmacogenomics improved. The team activities had a positive impact on student learning, and the course improved their confidence level to discuss pharmacogenomics with another health care provider or a patient. While 86% of the students considered themselves "unconfident," "somewhat unconfident" or "neither confident nor unconfident" at the beginning of the course, 91% reported being "confident" or "somewhat confident" by the end of the course. This increase in confidence was statistically significant. Furthermore, students showed knowledge retention six months after taking the course. Conclusion. Implementation of a new course in pharmacogenomics was effective and well received by the students. It also prepared students for system-based therapeutics courses later in the curriculum.

show abstract

Pharmacogenetic Information in Clinical Guidelines: The European Perspective

Swen¹,

Nijenhuis

Rhenen

et al. 2018

Clin Pharma and Therapeutics

View full text Add to dashboard Cite

Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx). In addition, patients are willing to consent to participate in PGx implementation studies. However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test. Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients..

show abstract

An Evaluation of Pharmacists‘ Expectations Towards Pharmacogenomics

Abstract: Pharmacists are extremely hopeful towards pharmacogenomic testing. Furthermore, a vast majority is willing to integrate these tests as part of their clinical practice. Proper education will be required if the integration of pharmacogenomics in patient care is to be optimal.

Cited by 73 publications

References 46 publications

Knowledge, Attitude and Practice Concerning Pharmacogenomics among Pharmacists: A Systematic Review

Knowledge, Attitude and Practice Concerning Pharmacogenomics among Pharmacists: A Systematic Review

An Effective Approach to Teaching Pharmacogenomics in the First Year of Pharmacy Curriculum

Pharmacogenetic Information in Clinical Guidelines: The European Perspective

Contact Info

Product

Resources

About